Response to Smith

Am J Psychiatry. 2014 Nov 1;171(11):1223-4. doi: 10.1176/appi.ajp.2014.14070827r.

Authors

Barbara Olasov Rothbaum¹, Matthew Price, Kerry Ressler

Affiliation

¹ From the Trauma and Anxiety Recovery Program, Emory University School of Medicine, Atlanta; the University of Vermont, Burlington, Vt.; and the Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine.

PMID: 25756637
DOI: 10.1176/appi.ajp.2014.14070827r

No abstract available

Publication types

Comment

MeSH terms

Alprazolam / therapeutic use*
Anti-Anxiety Agents / therapeutic use*
Cycloserine / therapeutic use*
Female
Humans
Male
Stress Disorders, Post-Traumatic / therapy*
Veterans / psychology*
Virtual Reality Exposure Therapy / methods*

Substances

Anti-Anxiety Agents
Cycloserine
Alprazolam